-
Blood: High plasma GDF-15 levels are associated with an increased risk of venous thrombosis.
Time of Update: 2020-09-02
results of this study show that high GDF-15 levels are associated with increased risk of VTE, but Mendel's random analysis suggests that this link is not causal.
-
Is a blood transfusion a full blood transfusion? You may need to enter plasma!
Time of Update: 2020-09-02
(11) to fight a drug overdose and need to infus fresh frozen plasma.
-
Blood: Hereditary alpha-trypsinemia is an effective genetic biomarker of hypertrophic cell hypertrophic disorder.
Time of Update: 2020-09-01
assessed the TPSAB1 embryonic copy number variation in 180 hypertrophic cell hypertrophic patients, 180 gender-matched control individuals, 720 other myelin tumor patients, and an additional 61 hypertrophic cell hypertrophic patients in a separate validation queue with PCR.
-
Blood: Emicizumab treats obtained haemophilia A.
Time of Update: 2020-09-01
bypass therapy, human or pig FVIII is currently the standard treatment for AHA hemolysis.
-
JAMA: Red blood cell infusion and risk of poor prognostication in very low-weight newborns.
Time of Update: 2020-09-01
study found that for babies born weighing less than 1,000 grams, not limiting red blood cell infusions did not reduce the risk of death or disability at 24 months.
-
Lancet oncol: Liu-Inspired Team - Phase III Clinical Trials - AML After Transplantation, Sorafini is used to maintain the efficacy and tolerability of the treatment.
Time of Update: 2020-09-01
Retrospective results showed that Sorafini maintenance therapy or reduced recurrence after transplantation of heteroglytic stem cells in patients with acute myeloid leukemia carrying FLT3-ITD internal series repetition (FLT3-ITD). , director
-
Blood: Myeloid ancestors from bone marrow sources are carriers of mutations driven by longeghans cell tissue cell growth.
Time of Update: 2020-09-01
Langehans cell tissue cellular growth disorder (LCH) is a myelin tumor driven by an occasional activation mutation in the MAPK path. 's "misleading myelin dendritic cell (DC)" model suggests that high-risk, multi-system, hazardous organ
-
Lancet haematol: Clinical characteristics and adverse prognostic factors in patients with blood malignancies infected with COVID-19.
Time of Update: 2020-09-01
the study cohort had a standardized mortality rate of 41.3 (38.1-44.9) compared to patients with non-COVID-19 infected blood malignancies.
-
Blood: Avelumab treats recurrent/incurable NK/T cell lymphoma.
Time of Update: 2020-09-01
therefore, tumor tissue in all patients receiving CR had high expression of PD-L1, and tumor substations based on PD-L1 expression were associated with therapeutic responses.
-
NEJM: Venetoclax Treatment of Acute Myeloid Leukemia (AML), Phase III Clinically Positive Results.
Time of Update: 2020-09-01
AbbVie announced today that the results of Phase III clinical trials (VIALE-A) published in the New England Journal of Medicine (NEJM) assessed the effectiveness and safety of veetoclax in the treatment of primary AML patients, and showed
-
Blood: Targeting VWF prevents traumatic brain injury-induced clotting.
Time of Update: 2020-09-01
shock, but the exact mechanism of occurrence is still unclear. in the study, the researchers reported findings that validated the hypothesis that "the von Willebrand factor (VWF) released during acute TBI is inherently highly adhesionable
-
Same case, but with different results, who is changing?
Time of Update: 2020-09-01
with blood disease? When it was learned that the patient has no history of blood disease, 4 days ago in the hospital also tested on an empty stomach blood sugar, glycated hemoglobin, insulin, C peptide and urine analysis and other diabetes screening items
-
Blood: Prostatin E2 restores the sensitivity of leukemia cells to glucoscosteroids.
Time of Update: 2020-09-01
In addition, the researchers found that prostatin E recepposer 4 was expressed in T-ALL samples and demonstrated that prostin E2 (PGE2) increases in-cell cAMP, enhances GC-induced gene expression, and makes T-ALL samples sensitive to desermison.
-
J Thromb Haemost: Retinal vascular blockage of adult hereditary or obtainable thrombosis tendencies.
Time of Update: 2020-09-01
of thrombosis. Recently, a study published in Journal of Thrombosis and Haemostasis, the authoritative journal of thrombosis and clotting disease, aims to assess the prevalence of hereditary or inherited thrombosis tendencies in adults with RAO
-
Blood: Hemococotin deficiency promotes acute kidney damage in patients with sickle cell disease!
Time of Update: 2020-09-01
Center point: In sickle cell disease (SCD), the ratio of plasma alpha-1 microglobulin to hemacoglobin concentration is associated with AKI biomarkers.
-
Blood: New sub-type - tissue resident memory B cells.
Time of Update: 2020-09-01
, the study provides new insights into the functional characteristics of human B-cell chambers in multiple tissues.
-
Blood: CBRN multiple mutations associated with multiple myeloma and drug resistance to lysamine or pomadamine.
Time of Update: 2020-09-01
it is understood that this study is the first comprehensive analysis of CBRN variation in patients with myeloma who are progressing in treatment, which can help guide patients to choose the sequence therapy of CRBN-targeted drugs.
-
Inventory: A selection of Blood studies dated August 13, 2020.
Time of Update: 2020-09-01
Most bleeding abnormalities are associated with coagulation factor dysfunction, and researchers recently established a cell-based analysis method to determine drugs that may have off-target effects that affect active vitamin K dependence (VKD) coagulation factor biosynthesis.
-
NEJM: Vinetola combined with aza cytoside to treat acute myeloid leukemia in old age.
Time of Update: 2020-09-01
studies have concluded that Vinetola combined azadenosine can effectively prolong the survival of elderly patients with acute myeloid leukemia aged 75 years and older.
-
The cause of anemia is too complex, these 3 tests are easy to identify!
Time of Update: 2020-09-01
And, in other anemia diseases that are easily confused with iron deficiency anemia or giant larvae anemia (e.g. iron granulocytic anemia, thalassemia, bone marrow growth abnormal syndrome, etc.), the three anemias are also of great significance for differential diagnosis.
